{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:28:33Z","timestamp":1760239713262,"version":"build-2065373602"},"reference-count":38,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Arterial hypertension affects the survival of the kidney graft and the cardiovascular morbidity and mortality of the recipient after kidney transplantation (KTx). Thus, antihypertensive treatment is necessary for a vast majority of these patients. Long-term data on antihypertensive drugs and their effects on allograft function after KTx is still limited, and further investigation is required. We retrospectively analyzed a cohort of 854 recipients who received a kidney transplant at our transplant center between 2007 and 2015 with regard to antihypertensive treatment and its influence on graft function and survival. 1-y after KTx, 95.3% patients were treated with antihypertensive therapy. Of these, 38.6% received mono- or dual-drug therapy, 38.0% received three to four drugs and 8.1% were on a regimen of \u22655 drugs. Beta-blockers were the most frequently used antihypertensive agents (68.1%). Neither the use of angiotensin-converting enzyme inhibitor\/angiotensin receptor blockers (51.9%) and calcium channel blockers (51.5%), nor the use the use of loop diuretics (38.7%) affected allograft survival. Arterial hypertension and the number of antihypertensive agents were associated with unfavorable allograft outcomes (each p &lt; 0.001). In addition to the well-known risk factors of cold ischemic time and acute rejection episodes, the number of antihypertensive drugs after one year, which reflects the severity of hypertension, is a strong predictor of unfavorable allograft survival.<\/jats:p>","DOI":"10.3390\/jcm9123969","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T20:18:22Z","timestamp":1607631502000},"page":"3969","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antihypertensive Treatment in Kidney Transplant Recipients\u2014A Current Single Center Experience"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1136-438X","authenticated-orcid":false,"given":"Ulrich","family":"Jehn","sequence":"first","affiliation":[{"name":"Department of Medicine D, Division of General Internal Medicine, Nephrology and Rheumatology, University Hospital of M\u00fcnster, 48149 M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Sch\u00fctte-N\u00fctgen","sequence":"additional","affiliation":[{"name":"Department of Medicine D, Division of General Internal Medicine, Nephrology and Rheumatology, University Hospital of M\u00fcnster, 48149 M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Strauss","sequence":"additional","affiliation":[{"name":"Department of Medicine C, Division of Cardiology and Angiology, University Hospital of M\u00fcnster, 48149 M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Kunert","sequence":"additional","affiliation":[{"name":"Department of Medicine D, Division of General Internal Medicine, Nephrology and Rheumatology, University Hospital of M\u00fcnster, 48149 M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Pavenst\u00e4dt","sequence":"additional","affiliation":[{"name":"Department of Medicine D, Division of General Internal Medicine, Nephrology and Rheumatology, University Hospital of M\u00fcnster, 48149 M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3180-6245","authenticated-orcid":false,"given":"Gerold","family":"Th\u00f6lking","sequence":"additional","affiliation":[{"name":"Department of Medicine D, Division of General Internal Medicine, Nephrology and Rheumatology, University Hospital of M\u00fcnster, 48149 M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Suwelack","sequence":"additional","affiliation":[{"name":"Department of Medicine D, Division of General Internal Medicine, Nephrology and Rheumatology, University Hospital of M\u00fcnster, 48149 M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6345-6206","authenticated-orcid":false,"given":"Stefan","family":"Reuter","sequence":"additional","affiliation":[{"name":"Department of Medicine D, Division of General Internal Medicine, Nephrology and Rheumatology, University Hospital of M\u00fcnster, 48149 M\u00fcnster, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1111\/j.1600-6143.2008.02414.x","article-title":"2202 kidney transplant recipients with 10 years of graft function: What happens next?","volume":"8","author":"Matas","year":"2008","journal-title":"Am. J. Transplant."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1681\/ASN.2014080834","article-title":"Assessment and management of hypertension in transplant patients","volume":"26","author":"Weir","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_3","first-page":"217","article-title":"Association of chronic kidney graft failure with recipient blood pressure","volume":"53","author":"Opelz","year":"1998","journal-title":"Collab. Transpl. Study Kidney Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A Randomized Trial of Intensive versus Standard Blood-Pressure Control","volume":"373","author":"Wright","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/ajh\/hpz095","article-title":"Blood Pressure, Chronic Kidney Disease Progression, and Kidney Allograft Failure in Kidney Transplant Recipients: A Secondary Analysis of the FAVORIT Trial","volume":"32","author":"Malhotra","year":"2019","journal-title":"Am. J. Hypertens."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1097\/HJH.0b013e32834bd1e7","article-title":"Pathogenesis and management of hypertension after kidney transplantation","volume":"29","author":"Chatzikyrkou","year":"2011","journal-title":"J. Hypertens."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1034\/j.1600-6143.2002.20902.x","article-title":"Cardiovascular toxicities of immunosuppressive agents","volume":"2","author":"Miller","year":"2002","journal-title":"Am. J. Transpl."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.108.125674","article-title":"Dry-weight reduction in hypertensive hemodialysis patients (DRIP): A randomized, controlled trial","volume":"53","author":"Agarwal","year":"2009","journal-title":"Hypertension"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/5584_2016_84","article-title":"Hypertension in Chronic Kidney Disease","volume":"956","author":"Hamrahian","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/01.ASN.0000099379.61001.F8","article-title":"Transplant renal artery stenosis","volume":"15","author":"Bruno","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.2215\/CJN.01200211","article-title":"Metabolic syndrome in kidney transplantation: Management of risk factors","volume":"6","author":"Hricik","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.trre.2018.06.002","article-title":"Hypertension guidelines: How do they apply to kidney transplant recipients","volume":"32","author":"Aziz","year":"2018","journal-title":"Transpl. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000486905","article-title":"Treatment of Hypertension in Renal Transplant Recipients in Four Independent Cross-Sectional Analyses","volume":"43","author":"Adrych","year":"2018","journal-title":"Kidney Blood Press. Res."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia) (1997). Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet, 349, 1857\u20131863.","DOI":"10.1016\/S0140-6736(96)11445-8"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1432-2277.2009.00922.x","article-title":"Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients","volume":"22","author":"Hillebrand","year":"2009","journal-title":"Transpl. Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/ndt\/gfz092","article-title":"Comparative effectiveness of different antihypertensive agents in kidney transplantation: A systematic review and meta-analysis","volume":"35","author":"Pisano","year":"2020","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2215\/CJN.03170509","article-title":"Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease","volume":"5","author":"Ananthapanyasut","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/01.tp.0000235527.81917.fe","article-title":"Cardiovascular complications after renal transplantation and their prevention","volume":"82","author":"Ojo","year":"2006","journal-title":"Transplantation"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.trre.2017.11.002","article-title":"The evidence and rationale for the perioperative use of loop diuretics during kidney transplantation: A comprehensive review","volume":"32","author":"Sandal","year":"2018","journal-title":"Transpl. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ying, T., Shi, B., Kelly, P.J., Pilmore, H., Clayton, P.A., and Chadban, S.J. (2020). Death after Kidney Transplantation: An Analysis by Era and Time Post-Transplant. J. Am. Soc. Nephrol.","DOI":"10.1681\/ASN.2020050566"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J. Hypertens."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric Estimation from Incomplete Observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J. Am. Stat. Assoc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression Models and Life-Tables","volume":"34","author":"Cox","year":"1972","journal-title":"J. R. Stat. Soc. Ser. B Methodol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1053\/j.ajkd.2013.03.018","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for management of blood pressure in CKD","volume":"62","author":"Taler","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.transproceed.2018.02.128","article-title":"Influence of Polypharmacy on the Quality of Life in Stable Kidney Transplant Recipients","volume":"50","author":"Kolonko","year":"2018","journal-title":"Transpl. Proc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/157488631102160429003742","article-title":"A Systematic Approach to Assess the Burden of Drug Interactions in Adult Kidney Transplant Patients","volume":"11","author":"Bril","year":"2016","journal-title":"Curr. Drug Saf."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1681\/ASN.2017020216","article-title":"Understanding Medication Nonadherence after Kidney Transplant","volume":"28","author":"Nevins","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ishikawa, S., Naito, S., Iimori, S., Takahashi, D., Zeniya, M., Sato, H., Nomura, N., Sohara, E., Okado, T., and Uchida, S. (2018). Loop diuretics are associated with greater risk of sarcopenia in patients with non-dialysis-dependent chronic kidney disease. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0192990"},{"key":"ref_31","first-page":"12","article-title":"Protective Effects of Diuretics Against the Development of Cardiovascular Disease in Patients with Chronic Kidney Disease: A Systematic Review. Cardiovasc. Hematol","volume":"16","author":"Aomatsu","year":"2018","journal-title":"Agents Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2215\/CJN.05080418","article-title":"Association of Continuation of Loop Diuretics at Hemodialysis Initiation with Clinical Outcomes","volume":"14","author":"Sibbel","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000501315","article-title":"Loop Diuretics in Acute Kidney Injury Prevention, Therapy, and Risk Stratification","volume":"44","author":"Patschan","year":"2019","journal-title":"Kidney Blood Press. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/TP.0b013e3181a9e960","article-title":"Antihypertensives for Kidney Transplant Recipients: Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"88","author":"Cross","year":"2009","journal-title":"Transplantation"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","article-title":"Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial","volume":"285","author":"Agodoa","year":"2001","journal-title":"JAMA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1432-2277.2003.tb00306.x","article-title":"Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients","volume":"16","author":"Suwelack","year":"2003","journal-title":"Transpl. Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/j.1600-6143.2007.01928.x","article-title":"Renin Angiotensin System Blockade in Kidney Transplantation: A Systematic Review of the Evidence","volume":"7","author":"Hiremath","year":"2007","journal-title":"Am. J. Transpl."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1681\/ASN.V1341084","article-title":"Congestive heart failure in renal transplant recipients: Risk factors, outcomes, and relationship with ischemic heart disease","volume":"13","author":"Rigatto","year":"2002","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/12\/3969\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:42:02Z","timestamp":1760179322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/12\/3969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,7]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["jcm9123969"],"URL":"https:\/\/doi.org\/10.3390\/jcm9123969","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2020,12,7]]}}}